Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain
Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-120
SponsorGelscom SAS
About this trial
The purpose of this study is to assesse safety and efficacy of the Intradiscal Gelified Ethanol for treatment in refractory cervical discogenic pain.
Eligibility criteria
Qualifiers
Patient 18 years or older;
Pain refractory to conservative treatments for more than 2 months, non-surgical patients
Cervicobrachialgia due to disc herniation
Chronic discogenic pain (1 or 2 cervical discs) with concordant MRI;
Disqualifiers
Prior surgical treatment of the disc(s) studied;
Sick leave of more than 12 months secondary to painful symptoms;
Patient with Modic 1 score or more
History of cognitive-behavioral disorders that could affect the completion of self-questionnaires;
Trial design
Treatments tested in this trial
- Intradiscal Gelified Ethanol (Discogel)
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov